Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaas Oltmanns

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Die Rehabilitation|September 6, 2021
Jan Peters, Hans-Christian Köhler, Klaas Oltmanns, et al.
Die Rehabilitation|August 24, 2021
Jan Peters, Hans-Christian Köhler, Klaas Oltmanns, et al.
Virology Journal|January 10, 2024
Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 diseaseChristian M Zobel, Hartmut Kuhn, Maximilian Schreiner, et al.
Frontiers in Microbiology|November 8, 2023
Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progressionChristian Matthias Zobel, Werner Wenzel, Jan Philipp Krüger, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Die Rehabilitation|September 6, 2021
Jan Peters, Hans-Christian Köhler, Klaas Oltmanns, et al.
Die Rehabilitation|August 24, 2021
Jan Peters, Hans-Christian Köhler, Klaas Oltmanns, et al.
Virology Journal|January 10, 2024
Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 diseaseChristian M Zobel, Hartmut Kuhn, Maximilian Schreiner, et al.
Frontiers in Microbiology|November 8, 2023
Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progressionChristian Matthias Zobel, Werner Wenzel, Jan Philipp Krüger, et al.
Pageof 1